Prolacta breastmilk products for administration to critically ILL and premature infants in the neonatal intensive care unit
Ended Awarded
- Contract number
- HT009025FG0870069
- Awardee
-
Prolacta Bioscience, Inc. UEI VJUKD4ELEKD6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,247
Award facts
- Contract value 100% obligated
- $24,246.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- City of Industry, CA 91746, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $24,246.50 firm fixed price Blanket Purchase Agreement (BPA) call contract to Prolacta Bioscience, Inc. on July 28, 2025, with completion scheduled for September 30, 2025. This task order is for the provision of Prolacta breastmilk products specifically designed for administration to critically ill and premature infants in neonatal intensive care units (NICUs). The contract carries no set-aside designation and will be performed at the contractor's facility in Bassett, California. Prolacta Bioscience specializes in human milk-based nutritional products engineered to meet the complex dietary requirements of extremely low birth weight and premature newborns in military medical facilities.
This award represents a task order call against one of Prolacta's three existing indefinite delivery vehicles with the Defense Health Agency. These IDVs, valued at $1.75 million, $500,000, and $1.9 million respectively, collectively enable the DHA to procure an array of specialized milk-based products including fortifiers, donor human milk, and prenatal infant formulas for military medical centers. Prolacta Bioscience's federal contract history demonstrates an exclusive working relationship with the Defense Health Agency, consistently delivering critical nutritional support to neonatal patients across military healthcare facilities. All of the contractor's federal awards have been structured as firm fixed price BPA calls, reflecting the standardized and specialized nature of these essential neonatal care products.
Quick answers
Who was awarded contract HT009025FG0870069?
HT009025FG0870069 was awarded to Prolacta Bioscience, Inc. by Defense Health Agency (Department of Defense) on July 28, 2025.
How much is contract HT009025FG0870069 worth?
The government has obligated $24,247 on HT009025FG0870069.
Is contract HT009025FG0870069 an order under another contract?
Yes. HT009025FG0870069 is a BPA call under W81K0222A0010, a blanket purchase agreement.
Was contract HT009025FG0870069 competed?
The extent of competition for HT009025FG0870069 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award